Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Yarmouk University, Irbid, Jordan.
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom.
J Liposome Res. 2021 Jun;31(2):195-202. doi: 10.1080/08982104.2020.1768110. Epub 2020 May 28.
Niosome nanoparticles can be prepared using different methods, each of which can affect the size and homogeneity of the prepared particles. The aim of this study was to establish if the method of preparation impacted on the prepared vesicles when loaded with a model protein and the type of immune responses induced to the vaccine antigen. Niosomes were prepared using both the traditional thin film hydration (TFH) technique and the microfluidic mixing (MM) technique. Influenza antigen was then entrapped in the niosomes and formulations tested for their ability to induce in immune responses in immunised BALB/c mice. Niosomes prepared by MM had a mean size of 157 ± 1.8 nm and were significantly more uniform compared with the niosomes prepared using TFH (mean size 388 ± 10 nm). Niosomes play a key role as an adjuvant to help raise high antibody immune responses. This was confirmed in this study since animals treated with both types of niosomes and antigen were more responsive than unentrapped (free) antigen. Cytokine analysis showed that the TFH niosomes induced a Th1 immune response by raising IgG2a and high levels of IFN-ɣ, while the MM niosomes induced a Th2 immune response by inducing IgG1 ( < .05). These results confirmed that the method of preparation of the niosomes nanoparticles induced different immune responses and the average particle size of the niosomes differed depending on the method of manufacture. This indicates that particle size and uniformity are of importance and should be taken into consideration when designing an oral based delivery system for vaccine delivery.
泡囊纳米颗粒可以通过不同的方法制备,每种方法都会影响所制备颗粒的大小和均一性。本研究旨在确定制备方法是否会影响包封模型蛋白的泡囊,以及对疫苗抗原诱导的免疫反应类型。使用传统的薄膜水化(TFH)技术和微流混合(MM)技术制备了泡囊。然后将流感抗原包封在泡囊中,并测试其在免疫 BALB/c 小鼠中诱导免疫反应的能力。通过 MM 制备的泡囊平均粒径为 157±1.8nm,与通过 TFH 制备的泡囊(平均粒径 388±10nm)相比,粒径更均匀。泡囊作为佐剂在帮助提高抗体免疫反应中起着关键作用。本研究证实了这一点,因为用两种类型的泡囊和抗原处理的动物比未包封(游离)抗原的动物反应更强烈。细胞因子分析表明,TFH 泡囊通过提高 IgG2a 和高水平 IFN-γ引起 Th1 免疫反应,而 MM 泡囊通过诱导 IgG1 引起 Th2 免疫反应(<0.05)。这些结果证实,泡囊纳米颗粒的制备方法诱导了不同的免疫反应,泡囊的平均粒径取决于制造方法的不同。这表明粒径和均一性很重要,在设计基于口服的疫苗传递系统时应加以考虑。